Stay updated on Pembrolizumab for Leukoplakia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page
- CheckyesterdayChange DetectedAugust 2026 dates were added to the Study Record Dates and older July dates were removed, reflecting an update to the revision history for NCT03603223.SummaryDifference0.2%

- Check15 days agoChange DetectedFooter revision tag updated from v3.6.4 to v3.6.5, indicating a minor site update. No changes to study content or user actions.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study record's update dates were modified. Three new timestamps were added (2026-07-07, 2026-07-09, 2028-08-01) and three older timestamps were removed (2025-07-28, 2025-07-30, 2026-08-01).SummaryDifference0.3%

- Check51 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, indicating a newer build of the page template or related site software. This appears to be an internal maintenance update rather than a change to study data or eligibility.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.